← All trials

NCT06562673

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Aug 20, 2024
Primary completion
Apr 20, 2025
Completion date
Apr 20, 2025
First posted
Aug 20, 2024
Last posted
Aug 22, 2024
Enrollment
10
Arms / groups
1 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.